Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Ex vivo expansion of haematopoietic stem cells and gene therapy development.

Zubler RH.

Swiss Med Wkly. 2007 Mar 2;137 Suppl 155:31S-35S.

PMID:
17874498
2.

Ex vivo expansion of hematopoietic stem cells and gene therapy development.

Zubler RH.

Swiss Med Wkly. 2006 Dec 23;136(49-50):795-9. Review.

PMID:
17299657
3.

Transduction of CpG DNA-stimulated primary human B cells with bicistronic lentivectors.

Kvell K, Nguyen TH, Salmon P, Glauser F, Werner-Favre C, Barnet M, Schneider P, Trono D, Zubler RH.

Mol Ther. 2005 Nov;12(5):892-9. Epub 2005 Jul 11.

4.
5.

Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors.

Bovia F, Salmon P, Matthes T, Kvell K, Nguyen TH, Werner-Favre C, Barnet M, Nagy M, Leuba F, Arrighi JF, Piguet V, Trono D, Zubler RH.

Blood. 2003 Mar 1;101(5):1727-33. Epub 2002 Oct 24.

PMID:
12406892
6.

Naive and memory B cells in T-cell-dependent and T-independent responses.

Zubler RH.

Springer Semin Immunopathol. 2001 Dec;23(4):405-19. Review.

PMID:
11826617
7.

Transduction of CD34+ cells with lentiviral vectors enables the production of large quantities of transgene-expressing immature and mature dendritic cells.

Salmon P, Arrighi JF, Piguet V, Chapuis B, Zubler RH, Trono D, Kindler V.

J Gene Med. 2001 Jul-Aug;3(4):311-20.

PMID:
11529660
8.

IgG subclass switch capacity is low in switched and in IgM-only, but high in IgD+IgM+, post-germinal center (CD27+) human B cells.

Werner-Favre C, Bovia F, Schneider P, Holler N, Barnet M, Kindler V, Tschopp J, Zubler RH.

Eur J Immunol. 2001 Jan;31(1):243-9.

9.
10.

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.

Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C, Lawton P, Bixler S, Acha-Orbea H, Valmori D, Romero P, Werner-Favre C, Zubler RH, Browning JL, Tschopp J.

J Exp Med. 1999 Jun 7;189(11):1747-56.

12.

Quiescent memory B cells in human peripheral blood co-express bcl-2 and bcl-x(L) anti-apoptotic proteins at high levels.

Bovia F, Nabili-Tehrani AC, Werner-Favre C, Barnet M, Kindler V, Zubler RH.

Eur J Immunol. 1998 Dec;28(12):4418-23.

14.

Key differentiation steps in normal B cells and in myeloma cells.

Zubler RH.

Semin Hematol. 1997 Jan;34(1 Suppl 1):13-22. Review.

PMID:
9122741
16.
17.
18.

[Regulation of transcription of the interleukin-2 gene in B-lymphocytes].

Mouzaki A, Zubler RH.

Schweiz Med Wochenschr. 1995 Mar 4;125(9):396-9. French.

PMID:
7892566
19.
20.

Semiquantitative, nonradioactive RT-PCR detection of immunoglobulin mRNA in human B cells and plasma cells.

Matthes T, Kindler V, Zubler RH.

DNA Cell Biol. 1994 Apr;13(4):429-36.

PMID:
8011169
21.

In vitro function of peripheral blood and peritoneal B lymphocytes from CAPD patients.

Tucci A, Zubler RH, Campisi S, Cavatorta F, Favre H.

Perit Dial Int. 1994;14(1):84-6. No abstract available.

PMID:
8312424
22.

Similar CD40 ligand expression on EL-4 thymoma cell lines with widely different helper activity for B lymphocytes.

Werner-Favre C, Gauchat JF, Mazzei G, Aubry JP, Bonnefoy JY, Zubler RH.

Immunology. 1994 Jan;81(1):111-4.

23.

High IgE secretion capacity of human plasma cells.

Werner-Favre C, Matthes T, Barnet M, Zubler RH.

Eur J Immunol. 1993 Aug;23(8):2038-40.

PMID:
8344372
25.

Occurrence of a silencer of the interleukin-2 gene in naive but not in memory resting T helper lymphocytes.

Mouzaki A, Rungger D, Tucci A, Doucet A, Zubler RH.

Eur J Immunol. 1993 Jul;23(7):1469-74.

PMID:
8325322
26.
27.

Normal and atopic IgE responses.

Zubler RH, Zhang X, Tucci A, Polla BS, Werner-Favre C.

Springer Semin Immunopathol. 1993;15(1):29-36. Review. No abstract available.

PMID:
8362341
28.

Clonal imbalances of serum immunoglobulins after allogeneic bone marrow transplantation: an analysis by high-resolution two-dimensional gel electrophoresis.

Tissot JD, Helg C, Chapuis B, Zubler RH, Jeannet M, Hochstrasser DF, Hohlfeld P, Schneider P.

Bone Marrow Transplant. 1992 Oct;10(4):347-53.

PMID:
1422490
29.
30.

[Asthma, allergy, current aspects: IgE, atopy and parasites. Report of a 3A conference of January 25, 1992].

Koerffy A, Vercelli D, Zubler RH, Stadler BM, Moqbel R, Rochat T, Loutan L, Polla BS.

Rev Med Suisse Romande. 1992 Oct;112(10):879-84. French. No abstract available.

PMID:
1359623
31.

Effects of eleven cytokines and of IL-1 and tumor necrosis factor inhibitors in a human B cell assay.

Tucci A, James H, Chicheportiche R, Bonnefoy JY, Dayer JM, Zubler RH.

J Immunol. 1992 May 1;148(9):2778-84.

PMID:
1315359
32.

T cells from atopic individuals produce IgE-inducing activity incompletely blocked by anti-interleukin-4 antibody.

Zhang X, Polla B, Hauser C, Zubler RH.

Eur J Immunol. 1992 Mar;22(3):829-33.

PMID:
1547825
33.

Trans-active factors controlling the IL-2 gene in adult human T-cell subsets.

Mouzaki A, Zubler RH, Doucet A, Rungger D.

Mediators Inflamm. 1992;1(1):33-7.

34.

Frequencies of HIV-reactive B cells in seropositive and seronegative individuals.

Zubler RH, Perrin LH, Doucet A, Zhang X, Huang YP, Miescher PA.

Clin Exp Immunol. 1992 Jan;87(1):31-6.

35.

IL-4-dependent IgE switch in membrane IgA-positive human B cells.

Zhang XH, Werner-Favre C, Tang HY, Brouwers N, Bonnefoy JY, Zubler RH.

J Immunol. 1991 Nov 1;147(9):3001-4.

PMID:
1919002
36.

Are cord blood B cells functionally mature?

Tucci A, Mouzaki A, James H, Bonnefoy JY, Zubler RH.

Clin Exp Immunol. 1991 Jun;84(3):389-94.

38.

[Role of T lymphocytes in systemic lupus erythematosus].

Zubler RH, Miescher PA.

Ann Med Interne (Paris). 1990;141(3):208-12. Review. French.

PMID:
2195945
39.

Cell surface antigen CD5 is a marker for activated human B cells.

Werner-Favre C, Vischer TL, Wohlwend D, Zubler RH.

Eur J Immunol. 1989 Jul;19(7):1209-13.

PMID:
2474446
40.

[Basic principles of the humoral immune response].

Zubler RH.

Schweiz Med Wochenschr. 1989 Jan 7;119(1):3-8. Review. French.

PMID:
2521750
42.

B cell-stimulating activity of lymphoid cell membrane fractions.

Sekita K, Straub C, Hoessli D, Zubler RH.

Eur J Immunol. 1988 Sep;18(9):1405-10.

PMID:
3049119
43.

Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus.

Huang YP, Perrin LH, Miescher PA, Zubler RH.

J Immunol. 1988 Aug 1;141(3):827-33.

PMID:
3135313
44.

Quantitative analysis of precursors frequency of rheumatoid factor (RF) producing human B cells.

Vischer TL, Werner-Favre CF, Wen L, Zubler RH.

Scand J Rheumatol Suppl. 1988;75:123-6.

PMID:
3266359
45.

New approaches to the treatment of rheumatoid arthritis.

Miescher PA, Huang YP, Zubler RH.

Springer Semin Immunopathol. 1988;10(2-3):251-62. Review. No abstract available.

PMID:
3055380
46.

Theoretical and practical aspects of B-cell activation: murine and human systems.

Zubler RH, Werner-Favre C, Wen L, Sekita K, Straub C.

Immunol Rev. 1987 Oct;99:281-99. Review.

PMID:
2960608
47.

Limiting dilution assay for human B cells based on their activation by mutant EL4 thymoma cells: total and antimalaria responder B cell frequencies.

Wen L, Hanvanich M, Werner-Favre C, Brouwers N, Perrin LH, Zubler RH.

Eur J Immunol. 1987 Jun;17(6):887-92.

PMID:
3297736
49.

Supplemental Content

Loading ...
Support Center